Associations - WT1 mutation

BIOMARKER:

WT1 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

WT1 mutation WT1 mutation	Acute Myelogenous Leukemia AML	gilteritinib Resistant: B - Late Trials gilteritinib Resistant : B
WT1 mutation WT1 mutation	Acute Myelogenous Leukemia AML	venetoclax Resistant: C3 – Early Trials venetoclax Resistant : C3
WT1 mutation WT1 mutation	Acute Myelogenous Leukemia AML	TP-0903 Resistant: D – Preclinical TP-0903 Resistant : D
WT1 mutation WT1 mutation	Acute Myelogenous Leukemia AML	sorafenib + GMI-1359 Sensitive: D – Preclinical sorafenib + GMI-1359 Sensitive : D